文献速递脑血管病

脑缺血事件后的易损状态与稳定状态:SOCRATES、POINT和THALES试验动力学建模的意义

Vulnerable and Stabilized States After Cerebral Ischemic Events: Implications of Kinetic Modeling in the SOCRATES, POINT, and THALES Trials.
PubMed 文献 · Neurology · 2023-11-27

本研究对SOCRATES、POINT和THALES三项急性二级预防试验的Kaplan-Meier无复发生存曲线进行两状态动力学模型拟合。结果显示,易损状态复发率(k1)较稳定状态(k2)高约100倍,强化抗血小板治疗显著降低k1而不影响k0或k2,模型提示大部分获益发生在3天内。

要点

  • 两状态动力学模型较单状态模型或Weibull模型更好地拟合三项试验的生存曲线(p<0.05)。
  • 易损状态复发率(k1)约为稳定状态(k2)的100倍,向稳定状态转化率(k0)更快。
  • 强化抗血小板治疗仅显著降低k1,提示其作用局限于易损状态且获益多在3天内。

核心结论

  • 急性脑缺血事件后复发可用易损与稳定两状态动力学模型描述,强化抗血小板治疗仅影响易损状态复发率,且多数获益发生在3天内。

研究设计与样本

  • 对SOCRATES、POINT和THALES三项试验中各治疗组的Kaplan-Meier无复发生存曲线进行非线性回归拟合两状态动力学模型,标准误以非参数bootstrap重复重采样估计。

主要发现

  • 各试验中两状态模型拟合优于单状态模型或Weibull模型(p<0.05);易损状态复发率(k1)约为稳定状态(k2)的100倍;各试验间动力学参数一致,无显著差异。
  • 强化抗血小板方案显著降低k1(单用阿司匹林:0.030±0.004 d-1;活性治疗:0.016±0.003 d-1;p<0.01),但未影响k0或k2,提示活性治疗仅影响易损状态的风险。
  • 基于这些动力学参数的建模提示,活性治疗的大部分获益发生在3天内。

关键数值与推荐

  • 易损状态复发率(k1)较稳定状态(k2)高约100倍;强化抗血小板治疗使k1由单用阿司匹林的0.030±0.004 d-1降至活性治疗的0.016±0.003 d-1(p<0.01)。
  • 两状态模型较单状态模型或Weibull模型拟合更优(p<0.05),各试验间动力学参数无显著差异。

临床怎么用

  • 作者认为,急性脑缺血事件后存在两个不同状态,即刻或延迟治疗对其影响不同,提示强化抗血小板治疗的靶向与时程可据此考虑。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Trials of acute secondary prevention after minor stroke or transient ischemic attack (TIA), such as SOCRATES, POINT, and THALES, demonstrate a high initial rate of recurrence after ischemic events that drop quickly to a lower rate, suggesting a transient vulnerable clinical state, which may call for different treatments than the subsequent stabilized state. A kinetic model incorporating vulnerable and stabilized states provides estimates of the distinct kinetic rates reflecting the temporal features of underlying stroke mechanisms. We aimed to compare these kinetic rates between treatments and across trials, asking whether these features point to common pathophysiologic processes underlying stroke recurrence, and inform the targeting and timing of enhanced antiplatelet therapy in recurrent stroke prevention. METHODS: Kaplan-Meier recurrence-free survival curves in the SOCRATES, POINT, and THALES trials were estimated for each treatment group and fitted by nonlinear regression to the 2-state kinetic model, producing estimates of kinetic parameters, with standard errors estimated using the nonparametric bootstrap with repetitive resampling. RESULTS: For each trial, the 2-state kinetic model fit the survival curves better than did the null (single-state) kinetic model or the Weibull model (p < 0.05). Recurrence rates in the vulnerable state (k 1 ) were 100-fold higher than in the stabilized state (k 2 ). Transition rates from the vulnerable to stabilized state (k 0 ) were still more rapid. Kinetic parameters were consistent across the trials, without significant differences between the trials. Enhanced antiplatelet regimens produced significant reductions in k 1 (aspirin alone: 0.030 ± 0.004 d-1; active treatment: 0.016 ± 0.003 d-1; p < 0.01) but did not affect k 0 or k 2 , suggesting that active treatment only affected risk in the vulnerable state. Modeling based on these kinetic parameters suggests that most of the benefit of active treatment occurred within 3 days. DISCUSSION: Across multiple trials of acute secondary prevention after minor stroke or TIA, recurrence of stroke is well-described by a 2-state kinetic model postulating vulnerable and stabilized states, with similar kinetic parameters across trials. Enhanced antiplatelet regimens only affected the recurrence rates in the vulnerable state, over a brief period. This analysis suggests that 2 distinct states follow acute cerebral ischemic events, subject to differential impact of immediate or delayed therapies.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Brorson JR, Giurcanu M, Prabhakaran S, et al. Vulnerable and Stabilized States After Cerebral Ischemic Events: Implications of Kinetic Modeling in the SOCRATES, POINT, and THALES Trials. Neurology. 2023. PMID: 37857494. doi:10.1212/WNL.0000000000207904

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。